Figure 2.

Average level for each of the five health dimensions of EQ-5D depending on disease progression (Clinical stages I-IV) and whether patients receive antiretroviral treatment (ART) or not (No ART).

Robberstad and Olsen Cost Effectiveness and Resource Allocation 2010 8:5   doi:10.1186/1478-7547-8-5
Download authors' original image